ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,226Medicare Part D Prescriptions Filled, Including Refills

Rank: 617 out of 1383

$320K Total Retail Price of All Prescriptions

Rank: 638 out of 1383

151 Patients Receiving at Least One Drug in Part D
21%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 151 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

64% of this provider’s 151 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

7% of this provider’s 1,481 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
HYDROCODONE-ACETAMINOPHEN 724 94 S3 1 1
NORTRIPTYLINE HCL 293 22 2 236
LISINOPRIL 219 51 3 3
RAMIPRIL 185 64 4 80
METFORMIN HCL 183 74 5 8
GABAPENTIN 167 13 6 11
CARVEDILOL 159 44 7 24
PROMETHAZINE HCL 125 0 R 8 56
LYRICA 123 25 9 72
AMITRIPTYLINE HCL 105 48 R 10 57
PRAVASTATIN SODIUM 98 35 11 14
FUROSEMIDE 98 41 11 7
HYDROCHLOROTHIAZIDE 96 50 13 10
PROAIR HFA 93 15 14 42
AMLODIPINE BESYLATE 90 0 15 6
CRESTOR 89 38 16 34
ATORVASTATIN CALCIUM 74 22 17 18
SPIRIVA 73 20 18 45
CARISOPRODOL 73 25 R 18 76
NEXIUM 72 23 20 26
VENTOLIN HFA 71 0 21 93
PROPRANOLOL HCL 68 0 22 129
ESTRADIOL 68 0 R 22 96
IMIPRAMINE HCL 66 0 R 24 329
LEVOTHYROXINE SODIUM 65 26 25 4
ZOLPIDEM TARTRATE 64 0 26 17
CIMETIDINE 64 15 26 268
POTASSIUM CHLORIDE 64 24 26 12
NIFEDIPINE ER 63 25 29 126
PAROXETINE HCL 61 24 30 55
EVISTA 60 51 31 152
SEROQUEL XR 59 0 32 250
FLUOXETINE HCL 58 0 33 52
NIASPAN 58 14 33 148
TAMSULOSIN HCL 52 17 35 30
OMEPRAZOLE 51 0 36 5
CYMBALTA 51 0 36 53
NALBUPHINE HCL 50 0 38 451
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 23, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.